Peter Greenleaf - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of BioDelivery Sciences International Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioDelivery Sciences International Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BioDelivery Sciences International Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antares Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Greenleaf made no insider transaction in Avalo Therapeutics Inc (). Other recent insider transactions involving Avalo Therapeutics Inc () include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 6,083 shares made by Garry Arthur Neil .

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc () were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.

Avalo Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kiora Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sucampo Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sucampo Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sucampo Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Greenleaf made no insider transaction in Savara Inc (). Other recent insider transactions involving Savara Inc () include a net purchase of 289,000 shares made by David A Ramsay , a net purchase of 10,000 shares made by Raymond Dennis Pratt , and a net purchase of 333,333 shares made by Scott D Sandell .

In summary, during the past 3 months, insiders sold 0 shares of Savara Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 187,843 shares of Savara Inc () were sold and 3,632,330 shares were bought by its insiders, resulting in a net purchase of 3,444,487 shares.

Savara Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Greenleaf made no insider transaction in Synlogic Inc (). Other recent insider transactions involving Synlogic Inc () include a net sale of 6,810 shares made by Antoine Awad , a net sale of 19,042 shares made by Aoife Brennan , and a net sale of 2,553 shares made by Michael Vangsted Jensen .

In summary, during the past 3 months, insiders sold 560 shares of Synlogic Inc () in total and bought 0 shares, with a net sale of 560 shares. During the past 18 months, 28,593 shares of Synlogic Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 28,593 shares.

Synlogic Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Greenleaf made 3 insider transaction in Aurinia Pharmaceuticals Inc () with a net sale of 192,778. Other recent insider transactions involving Aurinia Pharmaceuticals Inc () include a net sale of 96,791 shares made by Stephen P. Robertson , a net sale of 57,505 shares made by Joseph M Miller , and a net sale of 28,644 shares made by Scott Michael Habig .

In summary, during the past 3 months, insiders sold 323,922 shares of Aurinia Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 323,922 shares. During the past 18 months, 474,747 shares of Aurinia Pharmaceuticals Inc () were sold and 65,000 shares were bought by its insiders, resulting in a net sale of 409,747 shares.

Aurinia Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.